JLE

Hépato-Gastro & Oncologie Digestive

MENU

Prise en charge des condylomes anaux chez l’adulte Volume 25, numéro 5, Mai 2018

  • [1] Abramowitz L, Benabderrahmane D, Ravaud P, et al. Anal squamous intraepithelial lesions and condyloma in HIV-infected heterosexual men, homosexual men and women: Prevalence and associated factors. AIDS 2007 ; 21 : 1457-65.
  • [2] Aubin F., Prétet J.L., Jacquard A.C., Saunier M. Human papillomavirus genotype distribution in external acuminata condylomata : a Large French National Study (EDiTH IV). Clin Infect Dis. 2008;47:610-615.
  • [3] Taylor S., Bunge E., Bakker M. The incidence, clearance and persistence of non-cervical human papillomavirus infections : a systematic review of the literature. BMC Infect Dis. 2016;16:293.
  • [4] Giuliano A.R., Lu B., Nielson C.M. Age-specific prevalence, incidence, and duration of human papillomavirus infections in a cohort of 290 US men. J Infect Dis. 2008;198:827-835.
  • [5] Morales R., Parada R., Giuliano A.R. HPV in female partners increases risk of incident HPV infection acquisition in heterosexual men in rural central Mexico. Cancer Epidemiol Biomarkers Prev. 2012;21:1956-1965.
  • [6] Glick S.N., Feng Q., Popov V. High rates of incident and prevalent anal human papillomavirus infection among young men who have sex with men. J Infect Dis. 2014;209:369-376.
  • [7] Grant R.M., Lama J.R., Anderson P.L. Preex-posure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363:2587-2599.
  • [8] Goodman M.T., Shvetsov Y.B., McDuffie K. Acquisition of anal human papillomavirus (HPV) infection in women : the Hawaii HPV Cohort study. J Infect Dis. 2008;197:957-966.
  • [9] Shvetsov Y.B., Hernandez B.Y., McDuffie K. Duration and clearance of anal human papillomavirus (HPV) infection among women : the Hawaii HPV cohort study. Clin Infect Dis. 2009;48:536-546.
  • [10] Assi R., Reddy V., Einarsdottir H. Longo, MD. Anorectal Human Papillomavirus. Current Concepts. 2014;87:537-547. 4
  • [11] Tanaka T.I., Alawi F. Human Papillomavirus and Oropharyngeal Cancer. Dent Clin North Am. 2018;62:111-120.
  • [12] Hernandez AL, Efird JT, Holly EA, et al. Incidence of and risk factors for type-specific anal human papillomavirus infection among HIV-positive MSM. AIDS 2014 ; 28 : 1341-9.
  • [13] Bouscarat F., Benabderrahmane D., Abramowitz L. Condylomes anaux. EMC Gastro- entérologie. 201219.
  • [14] Von Krogh G., Lacey C.J., Gross G. European course on HPV associated pathology : guidelines for primary care physicians for the diagnosis and management of anogenital warts. Sex Transm Infect. 2000;76:162-168.
  • [15] Grillo-Ardila CF et al. Imiquimod for anogenital warts in non-immunocompromised adults. Cochrane Database Syst Rev 2014.
  • [16] Miller R.L., Gerster J.F., Owens M.L. Imiquimod applied topically: A novel immune response modifier and new class of drug. Int J Immunopharmacol. 1999;21:1-14.
  • [17] Aubin F. Vaccination contre le papillomavirus humain : état des lieux. Ann Dermat Vener. 2012;139:339-343.
  • [18] Deshmukh AA, Cantor SB, Fenwick E, et al. Adjuvant HPV vaccination for anal cancer prevention in HIV-positive men who have sex with men : The time is now. Vaccine 2017 ; 35 : 5102-5109.
  • [19] Hyman M. Scott, Jeffrey D, et al. Sexually transmitted infections and pre-exposure prophylaxis: challenges and opportunities among men who have sex with men in the US. AIDS Res Ther 19 ; 13 : 5.
  • [20] Beaugerie L. High risk of anal and rectal cancer in patients with anal and/or perianal Crohn's disease. Clin Gastroenterol Hepatol. 2017;30:31414-31423.